2025 Schedule
November 13 – 14, 2025 • Ritz-Carlton Laguna Niguel,
Dana Point, CA
Schedule
PART I
Moving Personalized Medicine Forward: Advancements and Directions for the Future
SPEAKER | Daryl Pritchard, Ph.D., President, Personalized Medicine Coalition
MODERATOR | Lauren Silvis, J.D., Senior Vice President, External Affairs, Tempus
KEYNOTE SPEAKER | Peter Marks, M.D., Ph.D., Former Director, Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration
This session explores the cutting edge of personalized medicine beyond traditional gene testing, highlighting the clinical integration of next-generation diagnostic technologies. Experts will discuss the promise and practical application of proteomics, metagenomics, circulating tumor DNA (ctDNA), and digital diagnostic tools in delivering more precise, timely, and individualized care.
MODERATOR | Yuri Fesko, M.D., Senior Vice President & Chief Medical Officer, Quest Diagnostics
PANELIST | Esther Abels, Founder & CEO, SolarisRTC
PANELIST | Lourdes Barrera, Executive Director, Global Medical Affairs Oncology, Precision Medicine, Merck
PANELIST | David Kurtz, M.D., Ph.D., Co-Founder, Chief Medical Officer, Head of Research Foresight Diagnostics
PANELIST | Ofer Sharon, M.D., CEO, OncoHost
Industry innovation in diagnostic technologies and targeted treatment strategies drives progress in personalized medicine. But the path to market is fraught with obstacles. Pioneering investors and executives reflect on how to deal with challenges and uncertainty in an increasingly variable development and market environment.
MODERATOR | Kristin Ciriello Pothier, Life Sciences Sector Leader, Global Deal
Advisory and Strategy Leader, Healthcare and Life Sciences KPMG LLP
PANELIST | Namandjė Bumpus, Ph.D., Strategic Advisor, Healthcare Policies and Scientific Strategy, Avalere Health, Former U.S. FDA Principal Deputy Commissioner
PANELIST | Andy Moye, Ph.D., Senior Vice President and General Manager of Data Products, Tempus
PANELIST | Michael J. Pellini, M.D., Managing Partner, Section 32
MODERATOR | Invited
KEYNOTE SPEAKER | Helmy Eltoukhy, Ph.D., Co-Chief Executive Officer & Chairman of the Board, Guardant Health
KEYNOTE SPEAKER | AmirAli Talasaz, PhD., Co-Chief Executive Officer & Director, Guardant Health
By detecting molecular cancer signals in blood samples of seemingly healthy patients, a new generation of early cancer detection tests promises to put more patients on the path to personalized cancer treatment, sooner, when cancer may be more effectively treated. What might this mean for the future of cancer care? Leading voices discuss.
MODERATOR | Omar Perez, Ph.D., U.S. Head of Medical Diagnostics, AstraZeneca
PANELIST | Tomasz Beer, M.D., Chief Medical Officer, Multi-Cancer Early Detection, Exact Sciences
PANELIST | Eric Klein, M.D., Vice President, Distinguished Scientist, GRAIL
PANELIST | Dawn Mattoon, Ph.D., Chief Executive Officer, Mercy BioAnaytics, Inc.
PANELIST | Invited
MODERATOR | Invited
KEYNOTE SPEAKER | Invited
Machine Learning and Artificial intelligence technologies can drive biomarker discovery and validation and more readily explore divergent effects of preventive and treatment interventions across extensive data sets. What might this mean for the future of personalized medicine and what is being done to realize that future?
MODERATOR | Douglas Clark, M.D., Chief Pathologist, Life Sciences and Diagnostics Markets Group, Agilent Technologies
PANELIST | Michael Montalto, Ph.D., Vice President, Precision Medicine Global
PANELIST | Invited
PANELIST | Invited
PANELIST | Invited
PRESENTER | William S. Dalton, M.D., Ph.D., Founder & Senior Advisor, Aster Insights and Emeritus Senior Member, H. Lee Moffitt Cancer Center and Research Institute
AWARDEE | George Poste, D.V.M., Ph.D., Regents’ Professor and Del E. Webb Chair in Health Innovation and Chief Scientist, Complex Adaptive Systems Initiative, Arizona State University
MODERATOR | Dan Roden, M.D., Professor, Department of Medicine & Pharmacology, Senior Vice President, Personalized Medicine, and Professor Department of Biomedical Informatics, Vanderbilt University Medical Center
PANELIST | Doug Biehn, President & CEO, Octave Bioscience, Inc.
PANELIST | Brad Perkins, M.D., Chief Medical Officer, Karius Diagnostics
PANELIST | Invited
MODERATOR | David Morrow, Ph.D., Scientific Lead for Advanced Therapies, European Infrastructure for Translational Medicine (EATRIS)
PANELIST | Gabriele Allegri, Vice President, Global Commercial Precision Medicine, Johnson & Johnson Innovative Medicine
PANELIST | Ayah Ziyada, MSc. Ph.D. Candidate, Precision Medicine Program Manager, Center for Clinical Precision Medicine and Genomics, Hamad Medical Corporation, Qatar
PANELIST | Invited
PART II
Implementing Personalized Medicine in a New Era
SPEAKER | Lincoln Nadauld, M.D., Ph.D., President & CEO, Culmination Bio
MODERATOR | Invited
KEYNOTE SPEAKER | Invited
MODERATOR | Invited
PANELIST | Thomas Brown, M.D., Chief Medical Officer, Sygnomics
PANELIST | Okan Ekinci, M.D., Chief Medical Information Officer & Global Head of Digital Technology, Roche Information Solutions, Roche Diagnostics
PANELIST | Invited
Our scientific understanding and technological development for personalized medicine is way ahead of the policies and practices needed to fully realize the field’s value. Clinical implementation of personalized medicine technologies is fraught with challenges. A community approach to developing and implementing strategies to more consistently and effectively deliver personalized medicine is gaining traction. But, much is still needed to be done. What is needed to improve access and implementation?
MODERATOR | Burns Blaxall, Ph.D., Senior Vice President, Precision Medicine, Aranscia
PANELIST | Jonathan Katchmore, Associate Vice President, Commercial Diagnostic Strategy, Eli Lilly and Company
PANELIST | Prajit Pillai, Ph.D., Co-Founder and Head of Business Strategy & Technology Development, Precision Medicine Diagnostic Partners
PANELIST | Invited
PANELIST | Invited
LEARN MOREMODERATOR | Suzanne Belinson, Ph.D., Vice President of Commercial Markets, Tempus
PANELIST | Lon Castle, M.D., Chief Medical Officer, Precision Medicine, eviCore healthcare
PANELIST | Cate Lockhart, Pharm.D., Ph.D., Chief Science Officer, Academy of Managed Care Pharmacy
PANELIST | Kathryn Phillips, Ph.D., Founding Director, Center for Translational & Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco
PANELIST | Invited
SPEAKER | Daryl Pritchard, Ph.D., President, Personalized Medicine Coalition